Table II.

Subject demographics and underlying medical conditions

Subject	Age, years	Sex	Race	Hispanic or Latino	Medical history	Medications	Underlying disease status	Duration of lesions treated
1	23	Woman	White	Yes	Generalized morphea, gastroesophageal reflux disease	Tocilizumab, hydroxychloroquine, prednisone, tramadol, acetaminophen, pantoprazole	Slowly progressive	8 mo
2	72	Woman	White	No	Dermatomyositis, calcinosis cutis, hypertension, hyperlipidemia, hypothyroidism	Gabapentin, potassium chloride, atorvastatin, losartan, hydrochlorothiazide, amlodipine, primidone, levothyroxine, naproxen, cetirizine, alendronate, prednisone	Stable	20 y
3	51	Woman	White	No	Systemic sclerosis, calcinosis cutis, Raynaud phenomenon, osteoporosis; history of nephrolithiasis	Allopurinol, potassium citrate, alendronate, calcium, vitamin D3	Slowly progressive	>10 y
4	78	Woman	White	No	Systemic sclerosis, calcinosis cutis, Barrett esophagitis	None	Stable	>10 y
5	29	Man	White	Yes	Dermatomyositis, calcinosis cutis; history of gastrointestinal bleeding, transfusion	Methotrexate, prednisone, folic acid, oxycodone, morphine sulfate, hydroxychloroquine, oxandrolone, pantoprazole∗	Progressive	>2 y

^∗New medication for subject 5 added at 1-month follow-up. This subject was lost to follow-up after the 1-month follow-up visit.